[1]王佳欣,毛乾国.慢性乙型肝炎合并非酒精性脂肪性肝病 中医辨治的研究进展[J].医学信息,2019,32(16):38-40.[doi:10.3969/j.issn.1006-1959.2019.16.012]
 WANG Jia-xin,MAO Qian-guo.Advances in Research on TCM Syndrome Differentiation of Chronic Hepatitis B with Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2019,32(16):38-40.[doi:10.3969/j.issn.1006-1959.2019.16.012]
点击复制

慢性乙型肝炎合并非酒精性脂肪性肝病 中医辨治的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年16期
页码:
38-40
栏目:
综述
出版日期:
2019-08-15

文章信息/Info

Title:
Advances in Research on TCM Syndrome Differentiation of Chronic Hepatitis B with Nonalcoholic Fatty Liver Disease
文章编号:
1006-1959(2019)16-0038-03
作者:
王佳欣1毛乾国2
1.福建中医药大学,福建 福州 351012; 2.厦门市中医院感染病科,福建 厦门 361009
Author(s):
WANG Jia-xin1MAO Qian-guo2
1.Fujian University of Traditional Chinese Medicine,Fuzhou 351012,Fujian,China; 2.Department of Infectious Diseases,Xiamen Hospital of Traditional Chinese Medicine,Xiamen 361009,Fujian,China
关键词:
慢性乙型肝炎非酒精性脂肪性肝病辨证论治
Keywords:
Key words:Chronic hepatitis BNonalcoholic fatty liver diseaseSyndrome differentiation
分类号:
R575.5
DOI:
10.3969/j.issn.1006-1959.2019.16.012
文献标志码:
A
摘要:
慢性乙型肝炎是我国三大肝病之一,近年来随着人们生活习惯及饮食方式等改变,非酒精性脂肪性肝病患病率明显增高,两者并存于同一个体的现象较为普遍,病情更加复杂,治疗难度增大。中医药在促进肝脏脂肪代谢、提高抗病毒疗效、抗纤维化进展等方面展现了独特的优势。本文通过收集相关文献从中医学理、法、方药、非药物治疗等几个方面作为切入点,浅述慢性乙型肝炎合并非酒精性脂肪性肝病患者中医辨治的研究进展。
Abstract:
Abstract:Chronic hepatitis B is one of the three major liver diseases in China. In recent years, with the changes in people's living habits and dietary patterns, the prevalence of nonalcoholic fatty liver disease has increased significantly. It is common for both to coexist in the same individual. The condition is more complicated and the treatment is more difficult. Traditional Chinese medicine has shown unique advantages in promoting liver fat metabolism, improving antiviral efficacy, and anti-fibrosis progression. This article collects relevant literature from the aspects of Chinese medicine, law, prescription, non-drug treatment and other aspects as a starting point, and discusses the research progress of TCM differentiation and treatment of patients with chronic hepatitis B and nonalcoholic fatty liver disease.

参考文献/References:

[1]中华医学会肝病分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960. [2]中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):947-957. [3]张扬,扈晓宇,杨芳.温肾方治疗慢性乙型肝炎合并非酒精性脂肪性肝炎的随机对照临床研究[J].中华中医药杂志,2018,33(5):1975-1978. [4]刘奕,吴海柱.徐慧媛治疗慢性肝病的临床经验[J].中国临床医生杂志,2019,47(6):644-646. [5]徐建良,盛国光.盛国光教授从脾论治慢性肝病经验[J].中西医结合肝病杂志,2015,25(5):301-302. [6]袁梦,孙凤霞,王国玮.王国玮辨治慢性肝病经验初探[J].北京中医药,2019,38(4):315-319. [7]曾兰,盛国光.盛国光教授治疗肝病经验探析[J].中西医结合肝病杂志,2016,26(5):294-295. [8]汪涛.恩替卡韦联合肝癖Ⅰ号膏方治疗肝郁脾虚痰湿内蕴型慢性乙型肝炎合并非酒精性脂肪肝临床疗效观察[D].广西中医药大学,2017. [9]韩玉香,刘国旺,钱静,等.健肝降脂丸联合干扰素治疗慢性乙型肝炎合并非酒精性脂肪肝的疗效观察[J].天津医药,2014,42(6):610-612. [10]沈震,费新应,刘旭东.祛湿活血方对慢性乙型肝炎合并非酒精性脂肪性肝病患者抗病毒疗效的影响[J].湖北中医杂志,2015,37(8):38-39. [11]戴敏,肖阁敏,杨跃武.中医治疗乙肝合并脂肪性肝病的临床观察[J].医学理论与实践,2013(15):2030-2031. [12]姚向波,尹毅,周筱燕.十味诃子汤散联合恩替卡韦治疗老年慢性乙型肝炎合并非酒精性脂肪肝的临床研究[J].现代中药研究与实践,2017,31(6):72-76. [13]蒋厚勋.疏肝消脂汤治疗慢性乙型肝炎合并非酒精性脂肪肝49例[J].河南中医,2015,35(5):997-999. [14]袁超.“桃红化浊颗粒”联合恩替卡韦治疗慢乙肝合并脂肪肝临床观察[A]//中国中西医结合学会传染病专业委员会.第七次全国中西医结合传染病学术会议论文汇编[C].中国中西医结合学会传染病专业委员会:中国中西医结合学会.2016. [15]刘磊.双虎清肝颗粒治疗慢乙肝合并脂肪肝52例疗效观察[J].兵团医学,2014,40(2):34-35. [16]焦俊喆,关茜,王轲,等.消木丹颗粒联合恩替卡韦治疗慢性乙型病毒性肝炎合并非酒精性脂肪肝临床研究[J].四川中医,2018,36(9):80-83. [17]赵瑛.恩替卡韦联合血脂康胶囊治疗脂肪肝合并乙型肝炎的疗效及对病毒载量的影响[J].临床医学研究与实践,2018,3(30):13-14. [18]王景琦,李玉春,郝毅.温灸疗法治疗脾气虚型慢性乙型肝炎的效果分析[J].临床医药文献电子杂志,2018,5(41):63-64. [19]王海龙,许丽萍.推拿治疗非酒精性脂肪肝40例[J].武警医学,2016,27(8):853-854. [20]陈枝俏,谢燕萍,许娇,等.穴位注射联合贴敷治疗痰瘀型非酒精性脂肪肝[J].吉林中医药,2016,36(4):419-421.

相似文献/References:

[1]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
 LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2018,31(16):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[2]林晓岚,郑丽花,陈苑莉,等.微信随访对慢性乙型肝炎患者抗病毒治疗效果和 生活质量的影响研究[J].医学信息,2018,31(10):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
 LIN Xiao-lan,ZHENG Li-hua,CHEN Yuan-li,et al.Effect of WeChat Follow-up on Antiviral Treatment and Quality of Life in Patients with Chronic Hepatitis B[J].Journal of Medical Information,2018,31(16):164.[doi:10.3969/j.issn.1006-1959.2018.10.057]
[3]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
 CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Journal of Medical Information,2022,35(16):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[4]冯贺强,张彩红.肠道菌群与非酒精性脂肪肝关系的研究进展[J].医学信息,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
 FENG He-qiang,ZHANG Cai-hong.Research Progress on the Relationship between Intestinal Flora and Nonalcoholic Fatty Liver[J].Journal of Medical Information,2018,31(16):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
[5]林晓岚,陈苑莉.慢性乙型肝炎患者治疗依从性及其对生活质量的影响[J].医学信息,2018,31(13):168.[doi:10.3969/j.issn.1006-1959.2018.13.052]
 LIN Xiao-lan,CHEN Yuan-li.Treatment Compliance of Patients with Chronic Hepatitis B and its Influence on Quality of Life[J].Journal of Medical Information,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.13.052]
[6]郑 颖,孙华胜,毛乾国.中医防治非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(15):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
 ZHENG Ying,SUN Hua-sheng,MAO Qian-guo.Progress in Prevention and Treatment of Nonalcoholic Fatty Liver Disease by TCM[J].Journal of Medical Information,2018,31(16):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
[7]陈 欢,李秀惠.急、慢性乙型肝炎及乙肝肝硬化患者 肝功能及血脂水平分析[J].医学信息,2019,32(12):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
 CHEN Huan,LI Xiu-hui.Analysis of Liver Function and Blood Lipid Levels in Patients with Acute, Chronic Hepatitis B and Hepatitis B Cirrhosis[J].Journal of Medical Information,2019,32(16):67.[doi:10.3969/j.issn.1006-1959.2019.12.021]
[8]吴 刚,吴锦瑜.HBeAg阴性慢性乙型肝炎患者血清25-羟基维生素D3的检测及临床意义[J].医学信息,2018,31(19):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
 WU Gang,WU Jin-yu.Detection and Clinical Significance of Serum 25-hydroxyvitamin D3 in Patients with HBeAg-negative Chronic Hepatitis B[J].Journal of Medical Information,2018,31(16):96.[doi:10.3969/j.issn.1006-1959.2018.19.028]
[9]李珊珊,陈少彬,龚先琼.中药单体治疗非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(21):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
 LI Shan-shan,CHEN Shao-bin,GONG Xian-qiong.Advances in Research of Traditional Chinese Medicine Monomer in the Treatment of Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2018,31(16):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
[10]叶向荣.恩替卡韦治疗慢性乙型肝炎病毒感染的临床价值评价[J].医学信息,2018,31(22):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]
 YE Xiang-rong.Clinical Evaluation of Entecavir in Treatment of Patients with Chronic Hepatitis B Virus Infection[J].Journal of Medical Information,2018,31(16):147.[doi:10.3969/j.issn.1006-1959.2018.22.043]

更新日期/Last Update: 2019-08-15